This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Google Scholar Articles by Resnick, S. M. PubMed PubMed Citation Articles by Resnick, S. M. Related Collections Neuroendocrinology and Pituitary Female Endocrinology

Effects of Conjugated Equine Estrogens on Cognition and Affect in Postmenopausal Women with Prior Hysterectomy

National Institute on Aging (S.M.R., P.M.M.), Baltimore, Maryland 21224-6825; Wake Forest University Health Sciences (M.A.E., L.H.C., S.R.R.), Winston-Salem, North Carolina 27157; Medstar Research Institute (Y.A.), Hyattsville, Maryland 20785; Ohio State University (R.J.), Columbus, OH 43210; Stanford University (M.L.S.), Stanford, CA 94305; and University of Iowa (R.W.), Iowa City, IA 52242

Address all correspondence and requests for reprints to: Susan Resnick, Laboratory of Personality and Cognition, National Institute on Aging, Biomedical Research Center, 251 Bayview Boulevard, Baltimore, Maryland 21224-6825. E-mail: susan.resnick{at}nih.gov.

Context: Different menopausal hormone therapies may have varied effects on specific cognitive functions. We previously reported that conjugated equine estrogens (CEE) with medroxyprogesterone acetate had a negative impact on verbal memory but tended to impact figural memory positively over time in older postmenopausal women.

Objective: The objective of the study was to determine the effects of unopposed CEE on changes in domain-specific cognitive function and affect in older postmenopausal women with prior hysterectomy.

Design: This was a randomized, double blind, placebo-controlled clinical trial.

Setting: The study was conducted at 14 of 40 Women’s Health Initiative (WHI) clinical centers.

Participants: Participants were 886 postmenopausal women with prior hysterectomy, aged 65 yr and older (mean 74 yr), free of probable dementia, and enrolled in the WHI and WHI Memory Study (WHIMS) CEE-Alone trial for a mean of 3 yr and followed up for a mean of 2.70 yr.

Intervention: Intervention was 0.625 mg of CEE daily or placebo.

Main Outcome Measures: Annual rates of change in specific cognitive functions and affect, adjusted for time since randomization, were measured.

Results: Compared with placebo, unopposed CEE was associated with lower spatial rotational ability (P < 0.01) at initial assessment (after 3 yr of treatment), a difference that diminished over 2.7 yr of continued treatment. CEE did not significantly influence change in other cognitive functions and affect.

Conclusions: CEE did not improve cognitive functioning in postmenopausal women with prior hysterectomy. CEE was associated with lower spatial rotational performance after an average of 3 yr of treatment. Overall, CEE does not appear to have enduring effects on rates of domain-specific cognitive change in older postmenopausal women.